Olympus Korea said it has launched its latest endoscopy system, EVIS X1. 

EVIS X1 is equipped with a variety of technologies to help doctors more accurately examine and diagnose digestive and bronchial diseases in patients' stomachs, large intestines, and esophagus through endoscopy.

The device features include red dichromatic Imaging (RDI), which uses green, yellow, and red wavelengths to visualize blood vessels and increase the visibility of deep vessels and gastrointestinal bleeding sources, and texture and color enhancement imaging (TXI), which enhances the visibility of lesions by enhancing the texture, brightness, and color of the lesion area to make fine tissue differences more apparent. 

EVIS X1 also uses narrow band imaging (NBI), which uses blue and green light to increase the contrast between blood vessels and surrounding mucosa for more precise diagnosis, and brightness adjustment imaging with maintenance of contrast (BAI-MAC) function, which corrects the brightness of dark areas in endoscopic images while maintaining the brightness of bright areas.

Based on these key features, the company expects that the device will play a major role in preventing serious diseases such as colon cancer by enabling early detection of abnormalities in the gastrointestinal tract. 

In the future, the company plans to equip the device with artificial intelligence (AI) features to assist clinicians in diagnosis.

"EVIS X1 will help clinicians make accurate diagnoses in real-world clinical settings, enabling them to diagnose lesions such as cancer at an earlier stage," Olympus Korea Head of Business General Division Takeshi Tamai said. "With next-generation endoscopic products like EVIS X1, Olympus will further solidify its leadership as a global healthcare company, leading to effective treatment and improved patient outcomes."